Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Blin

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|September 22, 2020
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograftMaxime Jullien, Thierry Guillaume, Pierre Peterlin, et al.
American Journal of Hematology|January 2, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamideMaxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, et al.
Cancer Medicine|December 28, 2020
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Cytokine|April 30, 2019
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Bone Marrow Transplantation|August 16, 2020
Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experienceVanille Laurent, Clémentine Fronteau, Chloé Antier, et al.
Haematologica|January 12, 2019
FLT3 ligand plasma levels in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2020
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamidePatrice Chevallier, Ana Berceanu, Pierre Peterlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast NephropathyFrank Bridoux, Bertrand Arnulf, Lionel Karlin, et al.
Journal of Cancer Research and Clinical Oncology|May 4, 2022
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)Audrey Grain, Fanny Rialland-Battisti, Patrice Chevallier, et al.
Hemasphere|June 8, 2026
Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapyAustin Kulasekararaj, Flore S de Fontbrune, Anna Gaya, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|September 22, 2020
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograftMaxime Jullien, Thierry Guillaume, Pierre Peterlin, et al.
American Journal of Hematology|January 2, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamideMaxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, et al.
Cancer Medicine|December 28, 2020
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Cytokine|April 30, 2019
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Bone Marrow Transplantation|August 16, 2020
Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experienceVanille Laurent, Clémentine Fronteau, Chloé Antier, et al.
Haematologica|January 12, 2019
FLT3 ligand plasma levels in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.
Acta Oncologica (Stockholm, Sweden)|October 28, 2020
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamidePatrice Chevallier, Ana Berceanu, Pierre Peterlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast NephropathyFrank Bridoux, Bertrand Arnulf, Lionel Karlin, et al.
Journal of Cancer Research and Clinical Oncology|May 4, 2022
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)Audrey Grain, Fanny Rialland-Battisti, Patrice Chevallier, et al.
Hemasphere|June 8, 2026
Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapyAustin Kulasekararaj, Flore S de Fontbrune, Anna Gaya, et al.
Pageof 7